Low oil prices, volatility in the Chinese stock market, and geopolitical instability are all factors behind the economic uncertainty in emerging markets. Economists have their eye on the BRIC countries, as well as other developing economies, as they monitor for signs of slowing growth.
What does this mean for the medical device and diagnostics industry? Many of the largest medtech manufacturers have placed emphasis on the emerging markets in recent years, citing a large population in need of health care and rapid growth fueling infrastructure improvements. Will any potential emerging market shakiness correspond to weaker medtech sales? Or will the constant need for healthcare, no matter where the economy is headed, lend consistency to the medtech industry’s outlook?